These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 39430031)

  • 1. Dexamethasone implant for refractory macular edema secondary to diabetic retinopathy and retinal vein occlusion.
    Zhong YY; Tang C; Zhang LY; Zhang XD; Liu SL
    Int J Ophthalmol; 2024; 17(10):1837-1842. PubMed ID: 39430031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.
    Lam WC; Albiani DA; Yoganathan P; Chen JC; Kherani A; Maberley DA; Oliver A; Rabinovitch T; Sheidow TG; Tourville E; Wittenberg LA; Sigouin C; Baptiste DC
    Clin Ophthalmol; 2015; 9():1255-68. PubMed ID: 26203215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intravitreal dexamethasone implant (Ozurdex®) for retinal vascular diseases with macular edema: An observational study of real-life situations.
    Jirarattanasopa P; Jiranoppasakdawong S; Ratanasukon M; Bhurayanontachai P; Dangboon W
    Medicine (Baltimore); 2022 Jul; 101(27):e29807. PubMed ID: 35801769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the efficacy of dexamethasone implant and anti-VEGF for the treatment of macular edema: A systematic review and meta-analysis.
    Tang HX; Li JJ; Yuan Y; Ling Y; Mei Z; Zou H
    PLoS One; 2024; 19(7):e0305573. PubMed ID: 38985778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion.
    Giuffrè C; Cicinelli MV; Marchese A; Coppola M; Parodi MB; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):787-793. PubMed ID: 31897703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials.
    Xiaodong L; Xuejun X
    J Ophthalmol; 2022; 2022():4007002. PubMed ID: 35982771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.
    Li X; Wang N; Liang X; Xu G; Li XY; Jiao J; Lou J; Hashad Y;
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):59-69. PubMed ID: 29119239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the One-Year Efficacy of Combined Anti-VEGF and Dexamethasone Implant Treatment for Macular Edema in Retinal Vein Occlusions.
    Ren F; Gong H; Zhang H; Zhang X; Liu X; Li J; Zhang G
    Med Sci Monit; 2023 Jun; 29():e939277. PubMed ID: 37301978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravitreal aflibercept and dexamethasone implant in the treatment of macular edema associated with diabetic retinopathy or retinal vein occlusion: a Meta-analysis and systematic review.
    Qiu XY; Hu XF; Qin YZ; Ma JX; Liu QP; Qin L; Li JM
    Int J Ophthalmol; 2022; 15(9):1511-1519. PubMed ID: 36124196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion.
    Tatsumi T; Oshitari T; Baba T; Takatsuna Y; Yamamoto S
    Biomed Res Int; 2020; 2020():4529850. PubMed ID: 33274211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study.
    Mitchell P; Arnold J; Fraser-Bell S; Kang HK; Chang AA; Tainton J; Simonyi S
    BMJ Open Ophthalmol; 2023 Aug; 8(1):. PubMed ID: 37541745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 20. Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant.
    Castro-Navarro V; Monferrer-Adsuara C; Navarro-Palop C; Montero-Hernández J; Cervera-Taulet E
    BMC Ophthalmol; 2022 Apr; 22(1):191. PubMed ID: 35473615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.